Related Experiment Videos
Malignant hyperthermia--a large kindred linked to the RYR1 gene
A J Wallace1, W Wooldridge, H M Kingston
1Regional Molecular Genetics Laboratory, St Mary's Hospital, Manchester.
Anaesthesia
|January 1, 1996
Summary
Malignant hyperthermia susceptibility is genetically complex. Linkage analysis in one family suggests the ryanodine receptor gene is involved, enabling predictive DNA testing for at-risk individuals.
Area of Science:
- Genetics
- Molecular Biology
- Anesthesiology
Background:
- Malignant hyperthermia susceptibility (MHS) is genetically heterogeneous, with the ryanodine receptor (RYR1) gene on chromosome 19q and the adult muscle sodium channel alpha subunit gene on chromosome 17 implicated in different families.
- The in vitro muscle contracture test remains the gold standard for MHS diagnosis, but genetic linkage analysis offers predictive potential.
Purpose of the Study:
- To investigate genetic linkage in a large family with MHS, focusing on the RYR1 gene.
- To determine if RYR1 is the causative gene for MHS in this specific family.
- To establish accurate predictive genetic testing for MHS within the family.
Main Methods:
- Performed linkage analysis using intragenic RYR1 markers in a family with MHS.
- Conducted in vitro muscle contracture tests according to European Malignant Hyperthermia Group standards.
- Screened for known RYR1 mutations associated with MHS.
Main Results:
- No known MHS-associated RYR1 mutations were found in affected individuals.
- Strong evidence of genetic linkage to intragenic RYR1 markers was observed in the family.
- Accurate predictive DNA testing was successfully performed on 11 untested individuals at 50% risk.
Conclusions:
- The RYR1 gene is implicated in MHS in this family, despite the absence of previously identified mutations.
- Genetic linkage analysis provides a reliable method for MHS prediction in families with suspected RYR1 involvement.
- This study facilitates precise genetic counseling and predictive testing for MHS.